Posaconazole.
Invasive aspergillosis: no proven advantage, but may be a last resort for other serious mycoses.
D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy*; D005060:Europe; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*; D014230:Triazoles / Q000627:therapeutic use*
D000935:Antifungal Agents; D014230:Triazoles